(Source: Quarterhill Inc.)
  • Quarterhill’s (QTRH) International Road Dynamics (IRD) has been awarded two contracts worth $2.4 million for virtual weigh-in-motion (VWIM) systems by the Illinois State Toll Highway Authority
  • The subsidiary will install three VWIM systems at two sites to monitor commercial vehicles for weight, size and tire violations
  • President and CEO, Rish Malhotra, is confident that the Illinois Tollway will see benefits in terms of pavement preservation, improved safety, reduced congestion and lower costs
  • Quarterhill offers solutions in intelligent transportation systems and intellectual property licensing
  • Quarterhill (QTRH) is currently trading at $1.46

Quarterhill’s (QTRH) IRD has been awarded two contracts worth $2.4 million by the Illinois State Toll Highway Authority.

The contracts are for three VWIM systems at two locations for the Illinois State Police to monitor commercial vehicles for weight, size and tire violations. The project includes the installation of weight sensors, iSINC weigh-in-motion controllers, IP cameras, over-height detection sensors, and the Tire Anomaly and Classification System (TACS).

The TACS installations are the largest to date for IRD, with six lanes of TACS in one direction on I-294 northbound and three lanes in each direction on I-88 (eastbound/westbound).

The virtual weigh station web-based software will provide law enforcement with remote access to real-time data, including vehicle images, vehicle record data and reporting.

President and CEO, Rish Malhotra, is confident that the Illinois Tollway will see benefits in terms of pavement preservation, improved safety, reduced congestion and lower costs.

The new business expands IRD’s footprint on the Illinois Tollway network from two to five VWIM systems.

Quarterhill offers solutions in intelligent transportation systems and intellectual property licensing.

Quarterhill (QTRH) is currently trading at $1.46.

For full disclaimer information, please click here.


More From The Market Online

Optimi Health to advance psychedelic clinical trials

Optimi Health (CSE:OPTI) signs letter of intent with ATMA Journey Centers to advance its psilocybin extract into a psilocybin clinical trial.

@ the Bell: TSX falls in energy sell off

Canada’s main stock index loses ground from sagging commodity prices, but tech shares provide most of the gains on the TSX on Wednesday.